SAHPRA Registers Lenacapavir
Pretoria, 27 October 2025 – The South African Health Products Regulatory Authority (SAHPRA) is pleas...
27 October, 25 
 
 
 
 
							 
 

Pretoria, 27 October 2025 – The South African Health Products Regulatory Authority (SAHPRA) is pleas...
27 October, 25Picture a young girl watching her parents navigate the daily maze of diabetes management- checking b...
17 October, 25Pretoria, 15 October 2025 – The South African Health Products Regulatory Authority (SAHPRA) and the ...
15 October, 25Pretoria, 28 September 2025 – The South African Health Products Regulatory Authority (SAHPRA) wishes...
28 September, 25

The South African Health Products Regulatory Authority (SAHPRA) would like to inform healthcare prof...
06 June, 25There have been several cases around the world in which Tranexamic acid has been administered intrat...
21 December, 23The South African Health Products Regulatory Authority (SAHPRA) would like to inform you of a signal...
19 October, 21In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Roche Product...
10 November, 20
This recall is initiated because out of specification result observed for Assay of Propyl Parahydroxybenzoate (excipient) during routine stability testing of Vincristine Sulfate Injection.
The recall has been initiated due to a quality defect that may cause the needle to detach from the syringe body.
This recall is initiated due to contravention of Section 14 of the Medicines and Related Substances Act, 101 of 1965, as amended and contravention to the license conditions.

